Double-Blind Study of High-Dose Fluoxetine Versus Lithium or Desipramine Augmentation of Fluoxetine in Partial Responders and Nonresponders to Fluoxetine-Reference-Cited by-同舟云学术

Double-Blind Study of High-Dose Fluoxetine Versus Lithium or Desipramine Augmentation of Fluoxetine in Partial Responders and Nonresponders to Fluoxetine

Published:2002-08 Issue:4 Volume:22 Page:379-387
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:Journal of Clinical Psychopharmacology

Author:

Fava Maurizio,Alpert Jonathan,Nierenberg Andrew,Lagomasino Isabel,Sonawalla Shamsah,Tedlow Joyce,Worthington John,Baer Lee,Rosenbaum Jerrold F.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference45 articles.

1. DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION

2. Residual Symptoms in Depressed Patients Who Respond Acutely to Fluoxetine

3. Partial Response, Nonresponse, and Relapse With Selective Serotonin Reuptake Inhibitors in Major Depression

4. Possible synergism between fluoxetine and lithium in refractory depression

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy for Treatment-Resistant Depression;Psychiatric Clinics of North America;2023-06

2. Rethinking the medication management of major depression;Expert Review of Neurotherapeutics;2023-04-03

3. Fluoxetine plus lithium for treatment of mental health impairment in Long Covid;Discover Mental Health;2023-01-03

4. Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction;Expert Opinion on Therapeutic Targets;2022-12-02

5. Fluoxetine plus lithium for treatment of mental health impairment in Long Covid;2022-09-21